These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8236394)

  • 1. Coincidental severe Plasmodium falciparum infection and disseminated candidiasis.
    Soesan M; Kager PA; Leverstein-van Hall MA; van Lieshout JJ
    Trans R Soc Trop Med Hyg; 1993; 87(3):288-9. PubMed ID: 8236394
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchopulmonary candidiasis exacerbating asthma. Case report and review of the literature.
    Wengrower D; Or R; Segal E; Kleinman Y
    Respiration; 1985; 47(3):209-13. PubMed ID: 4001578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from pulmonary mucormycosis and candidiasis in diabetic ketoacidosis.
    Passi GR; Menon PS; Gupta DK; Lodha R
    Indian Pediatr; 1996 Dec; 33(12):1047-50. PubMed ID: 9141809
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Another case of disseminated candidiasis.
    Di Liberti JH; Hughes RA
    Pediatrics; 1975 Jun; 55(6):897-8. PubMed ID: 1134896
    [No Abstract]   [Full Text] [Related]  

  • 5. Fungal infection and haematological malignancies: a report about association therapy with amphotericin B and 5-flucytosine in primary lung involvement.
    Pogliani E; Clini E
    Haematologica; 1990; 75(3):304-5. PubMed ID: 2227636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of visceral mycoses, with special reference to drug therapy].
    Ikemoto H
    Nihon Rinsho; 1980 Nov; 38(11):4386-92. PubMed ID: 7253229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe pulmonary candidiasis during acute leukosis treated with amphotericin-B; clinical case].
    Sanguinetti M; Maresta A
    G Clin Med; 1968 Mar; 49(3):256-73. PubMed ID: 5266252
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
    Walsh TJ; Aoki S; Mechinaud F; Bacher J; Lee J; Rubin M; Pizzo PA
    J Infect Dis; 1990 Apr; 161(4):755-60. PubMed ID: 2138654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary candidiasis (report of a case)].
    Tomasević M; Mirić V
    Plucne Bolesti Tuberk; 1970; 22(4):351-5. PubMed ID: 5208402
    [No Abstract]   [Full Text] [Related]  

  • 11. [Candidiasis as a cause of systemic infection (author's transl)].
    Schütte H; Lazo M; Ferrada L; Retamal C
    Rev Med Chil; 1978 Dec; 106(12):1001-5. PubMed ID: 746254
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapy of generalized candidiasis of both lungs].
    Lampe W
    Med Welt; 1967 Feb; 5():282-6. PubMed ID: 5595146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects and therapy of candidiasis in pneumological patients].
    Perruchoud A; Kobza K; Kopp C; Mihatsch M; Herzog H
    Schweiz Med Wochenschr; 1977 Feb; 107(6):192-4. PubMed ID: 834994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal lung infections treated by 5 flucytosine.
    Symonds RP; Robertson AG; Stewart LM; Boyd G
    Scott Med J; 1982 Jul; 27(3):244-6. PubMed ID: 7112086
    [No Abstract]   [Full Text] [Related]  

  • 16. Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.
    Rodenhuis S; Beaumont F; Kauffman HF; Sluiter HJ
    Thorax; 1984 Jan; 39(1):78-9. PubMed ID: 6695357
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary aspergillosis complicating aplastic phase in hematologic patients.
    Capnist G; Chisesi T; Battista R; Dini E
    Haematologica; 1986; 71(3):201-4. PubMed ID: 3093323
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems in the treatment of pulmonary candidiasis].
    Oehling A; Martín-Gil D
    Rev Clin Esp; 1971 Jul; 122(2):123-6. PubMed ID: 5164619
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of pulmonary candidosis treated with amphotericin B].
    Bider F; Fiora L
    Minerva Med; 1965 Oct; 56(79):3364-7. PubMed ID: 5846623
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of 5-fluorocytosine therapy of aspergillosis and candidiasis].
    Rudnicka J; Halweg H; Krakówka P; Walczak J
    Pneumonol Pol; 1981 Mar; 49(3):209-17. PubMed ID: 7027197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.